Life science tools company Semba raises nearly $1 million

Semba BioSciences, a Madison, Wisconsin, company that makes devices geared toward purifying the increasing number of protein-based drugs on the market, has raised almost $1 million, according to regulatory filings.

The company said in June it expected to make $1 million this year, and would raise $750,000 to put toward sales and marketing of its Octave Chromatography System. The company raised $875,000, according to a recent regulatory filing.

Semba launched Octave in March. The device provides researchers screening and purification processes that Semba says are much more efficient than other methods.

The company also offers small molecule separation and bioseparation products.